METHODS FOR TREATING ACUTE CORONARY SYNDROME USING APOA-1 FUSION PROTEINS

RECOMBINANT PLASMID VECTORS, METHOD FOR PRODUCING ENZYMES THAT HYDROLYZE ORGANOPHOSPHATE, CARBAMATE, AND PYRETHROID INSECTICIDES, AND THE FORMULATION OF SUCH ENZYMES AS FUNCTIONAL COMPONENTS

Random Heteropolymers Preserve Protein Function in Foreign Environments

POLYNUCLEOTIDES ENCODING APOA-1 FUSION POLYPEPTIDES

RNASE-PON1 FUSION POLYPEPTIDES AND RELATED COMPOSITIONS AND METHODS

METHODS FOR TREATING RHEUMATOID ARTHRITIS USING CTLA4-PON1 FUSION PROTEINS

Polynucleotides encoding paraoxonase fusion polypeptides

A MICROBIAL ELECTROCHEMICAL TECHNOLOGY TO DETECT AND DEGRADE ORGANOPHOSPHATE PESTICIDES

DNASE FUSION POLYPEPTIDES AND RELATED COMPOSITIONS AND METHODS

MICROORGANISMS AND METHODS FOR PRODUCING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTYRATE

ORGANOPHOSPHORUS NERVE AGENT HYDROLYZING ENZYMES

Paraoxonase fusion polypeptides and related compositions and methods

LACTONASE AND STABILIZED MUTANTS THEREOF FOR TREATING FUNGAL INFECTIONS IN PLANTS

STABILIZED MUTANTS OF QUORUM QUENCHING LACTONASE AND USE THEREOF IN TREATMENT OF PATHOGENS

COMPOSITIONS COMPRISING AROMATIC DIPEPTIDES-BASED STRUCTURES ENCAPSULATING AN ESTERASE AND USES THEREOF

Random heteropolymers preserve protein function in foreign environments

POLYNUCLEOTIDES ENCODING APOA1-RNASE FUSION POLYPEPTIDES

Polynucleotides encoding APOA1-PON1 fusion polypeptides

Hydrogel-enzyme systems and methods

BIOREMEDIATION OF XENOBIOTICS IN THE HONEY BEE HIVE

Protein delivery to membranes

Random heteropolymers preserve protein function in foreign environments

PHOSPHOTRIESTERASE ENZYME TETHERED MONOMER

Mutated PTE enzymes

STABLE PROTEINS AND METHODS FOR DESIGNING SAME

PHOSPHOTRIESTERASES FOR TREATING OR PREVENTING ORGANOPHOSPHATE EXPOSURE ASSOCIATED DAMAGE

Variants of Phosphotriesterase for the Hydrolysis and Detoxification of Nerve Agents

Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage

APOA-1 FUSION POLYPEPTIDES AND RELATED COMPOSITIONS AND METHODS

Variants of phosphotriesterase for the hydrolysis and detoxification of nerve agents

Block Copolymer Complex Coacervate Core Micelles for Enzymatic Catalysis in Organic Solvent

Stable proteins and methods for designing same

Organophosphorous hydrolase variants

Vulcanisaetal phosphotriesterase-like lactonases (PLL) having enhanced properties and the uses thereof

Enzyme/Protein Packaged Bacterial Vesicles for Therapeutic Delivery

Sulfolobal phosphotriesterase-like (PLL) lactonases activity having enhanced properties and the uses thereof

Microorganisms and methods for producing (3R)-hydroxybutyl (3R)-hydroxybutyrate

Stabilization of biomolecules by attachment of responsive polymers and sensors thereof

ENZYME HAVING A NMDA RECEPTOR ANTAGONIST ACTIVITY AND/OR AN ANTICHOLINERGIC ACTIVITY

PHARMACEUTICAL FORMULATIONS COMPRISING PARAOXONASE

Treatment of Paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1

Enzymes for degrading organophosphates

DFPase enzymes from aplysia californica

Anti-trypanosomal peptides and uses thereof

Dynamic thermoresponsive nanoparticles for stabilization of enzymes at high temperatures

SERUM AND TISSUE BIOMARKERS OF HUMAN HCC

Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage

TREATMENT OF PRE-TERM NEONATES

DFPase enzymes from

Treatment of paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1

Anti-trypanosomal peptides and uses thereof

Dynamic thermoresponsive nanoparticles for stabilization of enzymes at high temperatures

Pharmaceutical formulations comprising paraoxonase

Pharmaceutical formulations, methods for treating chemical warfare agent exposure, and modified biomolecules